IQVIA Holdings (MIL:1IQV) Cyclically Adjusted Revenue per Share: €68.65 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1IQV IQVIA Holdings Inc MIL:1IQV
68 GF Score
Price €201.60
GF Value €211.72
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is IQVIA Holdings Cyclically Adjusted Revenue per Share?

IQVIA Holdings MIL:1IQV -1.90% 68 Cyclically Adjusted Revenue per Share is €68.65 as of Jun. 2026. GuruFocus rates MIL:1IQV with a GF Score™ of 68/100 and a GF Value™ of €211.72 (Fairly Valued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

IQVIA Holdings's adjusted revenue per share for the three months ended in Jun. 2026 was €22.662. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €68.65 for the trailing ten years ended in Jun. 2026.

During the past 12 months, IQVIA Holdings's average Cyclically Adjusted Revenue Growth Rate was 8.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of IQVIA Holdings was 8.90% per year. The lowest was 7.50% per year. And the median was 8.20% per year.

As of today (2026-08-01), IQVIA Holdings's current stock price is €201.60. IQVIA Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €68.65. IQVIA Holdings's Cyclically Adjusted PS Ratio of today is 2.94.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IQVIA Holdings was 5.17. The lowest was 1.88. And the median was 3.21.


IQVIA Holdings  (MIL:1IQV) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

IQVIA Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=201.60/68.65
=2.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of IQVIA Holdings was 5.17. The lowest was 1.88. And the median was 3.21.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


IQVIA Holdings Cyclically Adjusted Revenue per Share Related Terms


IQVIA Holdings Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for IQVIA Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IQVIA Holdings Cyclically Adjusted Revenue per Share Chart

IQVIA Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 66.74

IQVIA Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.34 66.45 66.74 71.09 68.65

MIL:1IQV vs WAT, NTRA, A: Cyclically Adjusted Revenue per Share Comparison

For the Diagnostics & Research subindustry, IQVIA Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IQVIA Holdings Cyclically Adjusted PS Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IQVIA Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where IQVIA Holdings's Cyclically Adjusted PS Ratio falls into.


MIL:1IQV
68GF Score
IQVIA Holdings Inc MIL:1IQV
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IQVIA Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IQVIA Holdings's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=22.662/333.9520*333.9520
=22.662

Current CPI (Jun. 2026) = 333.9520.

IQVIA Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 11.005 241.428 15.223
201612 9.162 241.432 12.673
201703 9.394 243.801 12.868
201706 9.428 244.955 12.853
201709 9.447 246.819 12.782
201712 9.945 246.524 13.472
201803 9.805 249.554 13.121
201806 10.469 251.989 13.874
201809 10.750 252.439 14.221
201812 11.582 251.233 15.395
201903 11.777 254.202 15.472
201906 12.088 256.143 15.760
201909 12.634 256.759 16.432
201912 13.233 256.974 17.197
202003 12.736 258.115 16.478
202006 11.727 257.797 15.191
202009 12.136 260.280 15.571
202012 13.881 260.474 17.797
202103 14.692 264.877 18.523
202106 14.641 271.696 17.996
202109 14.759 274.310 17.968
202112 16.502 278.802 19.766
202203 16.752 287.504 19.458
202206 17.529 296.311 19.756
202209 18.995 296.808 21.372
202212 18.725 296.797 21.069
202303 18.086 301.836 20.010
202306 18.430 305.109 20.172
202309 18.871 307.789 20.475
202312 19.225 306.746 20.930
202403 18.655 312.332 19.946
202406 19.225 314.175 20.435
202409 19.057 315.301 20.184
202412 20.918 315.605 22.134
202503 19.965 319.799 20.849
202506 20.108 322.561 20.818
202509 20.345 324.800 20.918
202512 21.706 324.054 22.369
202603 21.146 330.213 21.385
202606 22.662 333.952 22.662

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €68.65 mean?
IQVIA Holdings (MIL:1IQV) has a Cyclically Adjusted Revenue per Share of €68.65 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on IQVIA Holdings and its competitors.
Is IQVIA Holdings' Cyclically Adjusted Revenue per Share too high?
IQVIA Holdings' current Cyclically Adjusted Revenue per Share is €68.65. Overall, IQVIA Holdings has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IQVIA Holdings' Cyclically Adjusted Revenue per Share compare to WAT and NTRA?
IQVIA Holdings' Cyclically Adjusted Revenue per Share of €68.65 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on IQVIA Holdings and its competitors. IQVIA Holdings's current Cyclically Adjusted Revenue per Share is €68.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IQVIA Holdings stock overvalued right now?
Based on GuruFocus' analysis, IQVIA Holdings (MIL:1IQV) is currently considered Fairly Valued. The stock's GF Value™ is €211.72, compared to a current price of €201.60 — trading 4.8% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is €68.65. IQVIA Holdings' overall GF Score™ is 68/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For IQVIA Holdings (MIL:1IQV), the current Cyclically Adjusted Revenue per Share is €68.65 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IQVIA Holdings (MIL:1IQV) Overvalued in 2026?

Based on GuruFocus' analysis, IQVIA Holdings stock appears to be undervalued. The current stock price of €201.60 is trading 4.8% below its estimated GF Value™ of €211.72. GuruFocus considers IQVIA Holdings to be Fairly Valued.

Key valuation signals for MIL:1IQV:

  • Cyclically Adjusted Revenue per Share: €68.65
  • GF Value™: €211.72 vs. price of €201.60 (4.8% below fair value)
  • GF Score™: 68/100 with 8 warning signs

No single metric tells the full story. See the MIL:1IQV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IQVIA Holdings Business Description

Address 2400 Ellis Road, Durham, NC, USA, 27703
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
68GF Score

Get the complete analysis for MIL:1IQV

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€201.60
Price
€211.72
GF Value